tiprankstipranks
Genmab A/S (GMAB)
NASDAQ:GMAB

Compare Genmab (GMAB) vs. Competitors

777 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Genmab
$28.28
$17.38B
19.86
50.19%
8 Buy
2 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$56.30
$10.83B
32.67
-5.27%
13 Buy
3 Hold
0 Sell
Strong Buy
Incyte
$96.96
$19.30B
14.98
64.73%
8 Buy
8 Hold
1 Sell
Moderate Buy
Ascendis Pharma
$241.71
$14.84B
75.36%
13 Buy
0 Hold
0 Sell
Strong Buy
BioNTech SE
$91.98
$23.12B
-17.95
-2.29%
14 Buy
2 Hold
0 Sell
Strong Buy
Royalty Pharma
$48.30
$27.86B
21.65
49.67%
7 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GMAB
Genmab
28.28
9.47
50.35%
BMRN
BioMarin Pharmaceutical
56.30
-0.52
-0.92%
INCY
Incyte
96.96
40.09
70.49%
ASND
Ascendis Pharma
241.71
90.72
60.08%
BNTX
BioNTech SE
91.98
-4.54
-4.70%
RPRX
Royalty Pharma
48.30
17.09
54.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts